These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12939922)

  • 1. Do we need a national antiretroviral treatment register?
    Bekker LG; Wood R
    S Afr Med J; 2003 Jul; 93(7):514-5. PubMed ID: 12939922
    [No Abstract]   [Full Text] [Related]  

  • 2. Strategies for the scale-up of antiretroviral therapy in South Africa through health system optimization.
    Barker PM; McCannon CJ; Mehta N; Green C; Youngleson MS; Yarrow J; Bennett B; Berwick DM
    J Infect Dis; 2007 Dec; 196 Suppl 3():S457-63. PubMed ID: 18181694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV infection course without antiretroviral treatment in South Africa].
    Gjersvik P
    Tidsskr Nor Laegeforen; 2006 Nov; 126(23):3152. PubMed ID: 17171812
    [No Abstract]   [Full Text] [Related]  

  • 4. [HIV associated encephalopathy after highly active antiretroviral therapy (HAART)].
    Kishida S
    No To Shinkei; 2004 Apr; 56(4):301-10. PubMed ID: 15237721
    [No Abstract]   [Full Text] [Related]  

  • 5. ARV compliance--the new battle terrain.
    Bateman C
    S Afr Med J; 2004 Aug; 94(8):602-3, 605. PubMed ID: 15352575
    [No Abstract]   [Full Text] [Related]  

  • 6. Highly active antiretroviral therapy: a misnomer in HIV/AIDS terminology.
    Philpot R
    Intern Med J; 2004 Mar; 34(3):139. PubMed ID: 15030469
    [No Abstract]   [Full Text] [Related]  

  • 7. Highly active antiretroviral treatment in countries with very limited resources: do we have cheaper alternatives?
    Colebunders R; Florence E; Lynen L; Bouckenooghe A
    Int J STD AIDS; 2003 Jan; 14(1):1-5. PubMed ID: 12590784
    [No Abstract]   [Full Text] [Related]  

  • 8. Stirring the statistical pot.
    Bateman C
    S Afr Med J; 2004 Mar; 94(3):154-5. PubMed ID: 15098266
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drugs for antiretroviral therapy. The costs of HAART].
    Jablonowski H
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():21. PubMed ID: 19024911
    [No Abstract]   [Full Text] [Related]  

  • 10. HAART for hospital health care workers--an innovative programme.
    Uebel K; Friedland G; Pawinski R; Holst H
    S Afr Med J; 2004 Jun; 94(6):423-7. PubMed ID: 15250450
    [No Abstract]   [Full Text] [Related]  

  • 11. The medical miracle: more questions.
    Laurence J
    AIDS Read; 2005 Dec; 15(12):657-8. PubMed ID: 16355595
    [No Abstract]   [Full Text] [Related]  

  • 12. HAART less costly.
    AIDS Patient Care STDS; 2001 May; 15(5):289-90. PubMed ID: 11530771
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV/AIDS research in China: arising up from skyline.
    Shao YM
    Chin Med J (Engl); 2006 Dec; 119(23):1939-40. PubMed ID: 17199936
    [No Abstract]   [Full Text] [Related]  

  • 14. First national guidelines will help better control HIV/AIDS in China.
    Wang AX
    Chin Med J (Engl); 2006 Oct; 119(19):1587-8. PubMed ID: 17042971
    [No Abstract]   [Full Text] [Related]  

  • 15. A clinically dangerous flaw in reporting statistical significance.
    Campillo C; Puigventos F; Riera M
    Clin Infect Dis; 2006 Apr; 42(8):1205-6; author repy 1206-7. PubMed ID: 16575745
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interesting immunotherapy approach. An interferon as preload therapy].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():83. PubMed ID: 12043092
    [No Abstract]   [Full Text] [Related]  

  • 17. Emerging manifestations of HIV/AIDS: is it the virus or the antiviral therapy?
    Laurence J
    AIDS Read; 2001 Feb; 11(2):64-5. PubMed ID: 11279873
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiretroviral therapy: toxicity and adherence.
    Nadkar MY; Bajpai S
    J Assoc Physicians India; 2009 May; 57():375-6. PubMed ID: 19634282
    [No Abstract]   [Full Text] [Related]  

  • 19. [Assuring long-term success. Practicable therapy with fixed combination in a single tablet].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():81. PubMed ID: 12043088
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune reconstitution inflammatory syndrome after initiation of highly active anti-retroviral therapy in HIV/AIDS.
    Mohanty K
    Indian J Dermatol Venereol Leprol; 2010; 76(3):301-4. PubMed ID: 20445313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.